恶性潜能未定的肿瘤的临床试验
总计11339个结果
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)邀请报名
-
Children's Oncology GroupNational Cancer Institute (NCI); MedStar Georgetown University Hospital主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)主动,不招人
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
University of California, San FranciscoAkili Interactive Labs, Inc.完全的
-
South Eastern Health and Social Care Trust未知
-
National Cancer Institute (NCI)暂停
-
M.D. Anderson Cancer Center主动,不招人晚期恶性实体瘤 | 转移性恶性实体瘤 | 肝转移癌 | 肺转移癌 | 胸腔转移性恶性肿瘤美国
-
Jiangsu HengRui Medicine Co., Ltd.主动,不招人
-
Ohio State University Comprehensive Cancer Center完全的
-
University Hospital, Strasbourg, France完全的
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的
-
Northwestern University完全的
-
Washington University School of MedicinePfizer完全的
-
Masonic Cancer Center, University of MinnesotaNational Cancer Institute (NCI)招聘中
-
Children's Oncology Group尚未招聘
-
OHSU Knight Cancer InstituteOregon Health and Science University; National Center for Complementary and Integrative Health...招聘中
-
Douglas JohnsonIncyte Corporation招聘中
-
Children's Oncology GroupNational Cancer Institute (NCI)招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; American Cancer Society...招聘中
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)终止
-
City of Hope Medical CenterNational Cancer Institute (NCI)撤销造血和淋巴细胞肿瘤 | 恶性实体肿瘤
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Institute of Nursing Research (NINR); National Institutes...主动,不招人
-
Case Comprehensive Cancer Center撤销
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的胃食管结合部腺癌 | IIA 期食管癌 AJCC v7 | IIB 期食管癌 AJCC v7 | IIIA 期食管癌 AJCC v7 | IIIB 期食管癌 AJCC v7 | IIIC 期食管癌 AJCC v7 | 宫颈食管恶性肿瘤 | 胸段食管恶性肿瘤美国
-
Tianhong LiNational Cancer Institute (NCI); LabyRx Immunologic Therapeutics招聘中